General Information

The Journal of Bioethical Inquiry (JBI) publishes both reports of empirical research (using qualitative and/or quantitative methodologies) and articles that increase the theoretical understanding of medicine and healthcare, the health professions, and the biological sciences. The JBI is also open to critical reflections on medicine and conventional bioethics; the nature of health, illness, and disability; the sources of ethics; the nature of ethical communities; possible implications of new developments in science and technology for social and cultural life and human identity; and the impact of social policies and current world events on health, welfare, and systems of power.

We welcome contributions from from authors working in or across disciplines as well as perspectives that are less commonly published in existing journals in the field.

We encourage authors to write in a style that is accessible to readers from disciplines other than their own. Contributions discussing bioethical issues in different geographical and cultural settings are strongly encouraged.

Types of Manuscripts

  • Original Research
    • Including empirical and theoretical research and conceptual reflections
    • Recommended length: 7,000–8,000 words
  • Review Articles
    • Recommended length: 5,000 words
  • Critical Perspectives
    • Recommended length: 2,000–3,000 words
  • Critical Commentary and Opinion Pieces on Issues of Contemporary Interest
    • E.g., on articles published in the JBI or general editorials
    • Recommended length: 2,000 words
  • Case Reports and Case Studies Responses
    • Recommended length: 1,000–1,500 words
  • Book, Film, and Art Reviews
    • Recommended length: 1,500 words
  • Letters to the Editor
    • Recommended length: 500–1,000 words

Consideration

Manuscripts submitted to the Journal of Bioethical Inquiry must be offered exclusively to the journal. Submission of a manuscript implies that the work described:

  • Has not been published before;
  • Is not under consideration for publication anywhere else; and
  • Its publication has been approved by all co-authors, if any, as well as by the responsible authorities—tacitly or explicitly—at the institute where the work has been carried out.

The publisher will not be held legally responsible should there be any claims for compensation.

If a submitted article overlaps considerably with previously published articles or articles concurrently submitted elsewhere, copies of these should be included with the submitted manuscript.

Deadlines

Issue Number Paper
Submission
Peer
Reviewing
Copy/Style
Editing
Author
Approval
Publisher’s
Deadline
Publication
Date
Vol(1) June 1 Sept 1 Nov 1 Nov 15 Dec 1 March 1
Vol(2) Sept 1 Dec 1 Feb 1 Feb 15 March 1 June 1
Vol(3) Dec 1 March 1 May 1 May 15 June 1 Sept 1
Vol(4) March 1 June 1 Aug 1 Aug 15 Sept 1 Dec 1

Submitting a Manuscript

All submissions to the Journal of Bioethical Inquiry are completed using Editorial Manager, Springer’s fully web-enabled online manuscript submission and review system. Electronic submission substantially reduces the editorial processing and reviewing times and shortens overall publication times. It also offers authors the option of tracking the progress of their manuscripts in real time. For more information about submitting manuscripts using Editorial Manager, please see the “Authors” page.

Authors will be asked to submit a covering letter with each manuscript. This should detail:

  • Why the article should be published in the Journal of Bioethical Inquiry (in brief, a few lines only), and
  • Confirmation that the manuscript content (in part or in full) has not been submitted concurrently or published elsewhere.

Formatting Manuscripts

All manuscripts must conform to Chicago Author–Date style (Chicago cursive style). For more information about formatting, please see the JBI Style Guide page or the JBI Instructions for Authors.

  • If you are submitting a randomized controlled trial, please follow the CONSORT guidelines.
  • If you are submitting a systematic review, please follow the PRISMA (formerly QUOROM) guidelines.

Authorship

Authorship should be based on substantial contribution to:

  1. Conception and design of the article, or acquisition, analysis, and interpretation of data;
  2. Drafting of the article or revising it critically for important intellectual content; and
  3. Final approval of the version to be published.

Conditions (1), (2), and (3) must all be met by each author. Participation solely in the acquisition of funding or the collection of data does not justify authorship. Each author must also be prepared to take public responsibility for the article. The order of authors should be the joint decision of all authors.

Disclosure of Competing Interests and Funding

Authors are required to indicate whether they have any financial or professional relationships that may pose a competing interest.

A competing interest exists when professional judgement concerning a primary interest (such as patients’ welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise when authors have a financial professional interest that may influence, probably without their knowing, their interpretation of their results or those of others.

So that we make the best decision about how to handle a paper, we should know about any such competing interests authors may have. We are not aiming to eradicate dualities of interests, as these are inevitable, and we will not reject papers simply because of a duality of interest. However, we will make a declaration about whether or not competing interests exist.

Authors also are required to declare all sources of funding for their research. Authors must describe the role of study sponsor(s), if any, in the study design; in data collection, analysis, and interpretation; and in the writing of the article. They also should state whether the supporting source(s) controlled or influenced the decision to submit the final manuscript for publication. If sponsor(s) had no such involvement, this should be stated.

Ethical Approval

All experimental investigations involving human subjects must include a statement in the “Methods ” section that subjects gave their informed consent. The name of the ethics committee that approved the study also must be stated in this section. Additionally, the manuscript should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration (1964, last revised in 2000) of the World Medical Association. Do not use patients’ names, initials, or hospital numbers, especially in any illustrative material.

When reporting experiments on animals, indicate whether the institution’s or the National Research Council’s guide for, or any national law on, the care and use of laboratory animals was followed.

Studies involving Aboriginal or Torres Strait Islander subjects or any Indigenous populations also must state that they have been approved by the relevant local Indigenous representatives.

Patient Consent

Case reports must preserve patient anonymity; any identifying information should not be published unless it is essential for understanding the case.

Authors also must provide a signed statement (to be downloaded during the manuscript submission process) from the patient(s) or their surrogate giving permission for the publication of any identifying material. Where authors do not wish to include a signed patient consent to publish in the Journal of Bioethical Inquiry, reasons in support of this decision must be provided in a letter accompanying the manuscript.